![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 89
Zeitschriftenartikel
Wagner, Ferdinand 
ORCID: https://orcid.org/0000-0001-8565-8722; König, Stefanie; Wuermeling, Quirin Johannes; Sitzberger, Alexandra; Paolini, Marco; Weigert, Annabelle; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Endres, Felix; Schneller, Julia; Hubertus, Jochen; Holzapfel, Boris Michael; Birkenmaier, Christof und Ziegler, Christian Max
(2024):
Ultrasound supports clinical decision-making in determining the Sanders’ skeletal maturity score of the hand.
In: International Orthopaedics, Bd. 48: S. 1971-1978
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-8565-8722; König, Stefanie; Wuermeling, Quirin Johannes; Sitzberger, Alexandra; Paolini, Marco; Weigert, Annabelle; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Endres, Felix; Schneller, Julia; Hubertus, Jochen; Holzapfel, Boris Michael; Birkenmaier, Christof und Ziegler, Christian Max
(2024):
Ultrasound supports clinical decision-making in determining the Sanders’ skeletal maturity score of the hand.
In: International Orthopaedics, Bd. 48: S. 1971-1978
[PDF, 1MB]
Brioli, Annamaria ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
Hehlmann, Rüdiger und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
In: Leukemia, Bd. 38, Nr. 2: S. 465-466
[PDF, 286kB]
ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
In: Leukemia, Bd. 38, Nr. 2: S. 465-466
[PDF, 286kB]
Delazer, Luisa ORCID: https://orcid.org/0009-0002-1330-3628; Bao, Han; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Stauner, Livia; Nübling, Georg; Conrad, Julian ORCID: https://orcid.org/0000-0001-7912-0571; Noachtar, Soheyl ORCID: https://orcid.org/0000-0002-5623-7985; Havla, Joachim ORCID: https://orcid.org/0000-0002-4386-1340 und Kaufmann, Elisabeth ORCID: https://orcid.org/0000-0002-7582-2215
(2024):
Association between retinal thickness and disease characteristics in adult epilepsy: a cross‐sectional OCT evaluation.
In: Epilepsia Open, Bd. 9, Nr. 1: S. 236-249
[PDF, 831kB]
ORCID: https://orcid.org/0009-0002-1330-3628; Bao, Han; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Stauner, Livia; Nübling, Georg; Conrad, Julian ORCID: https://orcid.org/0000-0001-7912-0571; Noachtar, Soheyl ORCID: https://orcid.org/0000-0002-5623-7985; Havla, Joachim ORCID: https://orcid.org/0000-0002-4386-1340 und Kaufmann, Elisabeth ORCID: https://orcid.org/0000-0002-7582-2215
(2024):
Association between retinal thickness and disease characteristics in adult epilepsy: a cross‐sectional OCT evaluation.
In: Epilepsia Open, Bd. 9, Nr. 1: S. 236-249
[PDF, 831kB]
Schulz, Felicitas; Hauch, Ulrich; Ketzler-Henkel, Sandra; Heyde, Eyck von der; Koenigsmann, Michael; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Schulte, Nora und Germing, Ulrich
(2023):
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR.
In: Journal of Clinical Medicine, Bd. 12, Nr. 20, 6569
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Schulte, Nora und Germing, Ulrich
(2023):
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR.
In: Journal of Clinical Medicine, Bd. 12, Nr. 20, 6569
[PDF, 1MB]
Spinell, Thomas ORCID: https://orcid.org/0000-0003-2925-8761; Kröger, Annika; Freitag, Lena; Würfl, Gregor; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hickel, Reinhard und Kebschull, Moritz
(2023):
Dental implant material related changes in molecular signatures in peri-implantitis – A systematic review of omics in-vivo studies.
In: Dental Materials, Bd. 39, Nr. 12: S. 1150-1158
ORCID: https://orcid.org/0000-0003-2925-8761; Kröger, Annika; Freitag, Lena; Würfl, Gregor; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hickel, Reinhard und Kebschull, Moritz
(2023):
Dental implant material related changes in molecular signatures in peri-implantitis – A systematic review of omics in-vivo studies.
In: Dental Materials, Bd. 39, Nr. 12: S. 1150-1158
Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
Silzle, Tobias ORCID: https://orcid.org/0000-0001-6859-3090; Blum, Sabine; Kasprzak, Annika ORCID: https://orcid.org/0000-0001-7642-6751; Nachtkamp, Kathrin; Rudelius, Martina; Hildebrandt, Barbara; Götze, Katharina S. ORCID: https://orcid.org/0000-0002-6276-8002; Gattermann, Norbert; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127 und Germing, Ulrich
(2023):
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
In: Cancers, Bd. 15, Nr. 14, 3572
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-6859-3090; Blum, Sabine; Kasprzak, Annika ORCID: https://orcid.org/0000-0001-7642-6751; Nachtkamp, Kathrin; Rudelius, Martina; Hildebrandt, Barbara; Götze, Katharina S. ORCID: https://orcid.org/0000-0002-6276-8002; Gattermann, Norbert; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127 und Germing, Ulrich
(2023):
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
In: Cancers, Bd. 15, Nr. 14, 3572
[PDF, 1MB]
Siller, Sebastian ORCID: https://orcid.org/0000-0002-5236-4397; Kunz, Mathias; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Dimitriadis, Konstantinos ORCID: https://orcid.org/0000-0003-0417-2267; Dorn, Franziska; Tonn, Joerg-Christian und Schichor, Christian
(2023):
The impact of initial counselling for patients’ decision-making and the accuracy of interdisciplinary neurovascular board evaluation in elective treatment of unruptured intracranial aneurysms - a German single-centre retrospective study.
In: Clinical Neurology and Neurosurgery, Bd. 232, 107896
ORCID: https://orcid.org/0000-0002-5236-4397; Kunz, Mathias; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Dimitriadis, Konstantinos ORCID: https://orcid.org/0000-0003-0417-2267; Dorn, Franziska; Tonn, Joerg-Christian und Schichor, Christian
(2023):
The impact of initial counselling for patients’ decision-making and the accuracy of interdisciplinary neurovascular board evaluation in elective treatment of unruptured intracranial aneurysms - a German single-centre retrospective study.
In: Clinical Neurology and Neurosurgery, Bd. 232, 107896
Freitag, Lena; Spinell, Thomas ORCID: https://orcid.org/0000-0003-2925-8761; Kröger, Annika; Würfl, Gregor; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hickel, Reinhard und Kebschull, Moritz
(2023):
Dental implant material related changes in molecular signatures in peri-implantitis. A systematic review and integrative analysis of omics in-vitro studies.
In: Dental Materials, Bd. 39, Nr. 1: S. 101-113
ORCID: https://orcid.org/0000-0003-2925-8761; Kröger, Annika; Würfl, Gregor; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hickel, Reinhard und Kebschull, Moritz
(2023):
Dental implant material related changes in molecular signatures in peri-implantitis. A systematic review and integrative analysis of omics in-vitro studies.
In: Dental Materials, Bd. 39, Nr. 1: S. 101-113
Kirchner, Sophie-Kathrin; Lauseker, Michael; Adorjan, Kristina; Anderson-Schmidt, Heike; Anghelescu, Ion-George; Baune, Bernhardt T.; Budde, Monika; Dannlowski, Udo; Dietrich, Detlef E.; Fallgatter, Andreas J.; Falkai, Peter ORCID: https://orcid.org/0000-0003-2873-8667; Figge, Christian; Gade, Katrin; Heilbronner, Urs; Hiendl, Lena; Juckel, Georg; Kalman, Janos L.; Klöhn-Saghatolislam, Farahnaz; Konrad, Carsten; Lang, Fabian U.; Oraki Kohshour, Mojtaba; Papiol, Sergi; Reich-Erkelenz, Daniela; Reimer, Jens; Reininghaus, Eva Z.; Schaupp, Sabrina K.; Schmauß, Max; Schmitt, Andrea; Schulte, Eva Christina; Senner, Simon; Spitzer, Carsten; Vogl, Thomas; Zimmermann, Jörg; Hasan, Alkomiet; Schulze, Thomas G. und Senner, Fanny
(2022):
Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.
In: Frontiers in Psychiatry, Bd. 12, 713060
[PDF, 489kB]
ORCID: https://orcid.org/0000-0003-2873-8667; Figge, Christian; Gade, Katrin; Heilbronner, Urs; Hiendl, Lena; Juckel, Georg; Kalman, Janos L.; Klöhn-Saghatolislam, Farahnaz; Konrad, Carsten; Lang, Fabian U.; Oraki Kohshour, Mojtaba; Papiol, Sergi; Reich-Erkelenz, Daniela; Reimer, Jens; Reininghaus, Eva Z.; Schaupp, Sabrina K.; Schmauß, Max; Schmitt, Andrea; Schulte, Eva Christina; Senner, Simon; Spitzer, Carsten; Vogl, Thomas; Zimmermann, Jörg; Hasan, Alkomiet; Schulze, Thomas G. und Senner, Fanny
(2022):
Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.
In: Frontiers in Psychiatry, Bd. 12, 713060
[PDF, 489kB]
Wang, Katharina ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
Hehlmann, Rüdiger; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
Rautenberg, Christina; Stölzel, Friedrich; Germing, Ulrich; Schroeder, Thomas; Middeke, Jan Moritz und Lauseker, Michael
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Bd. 11, Nr. 10
[PDF, 1MB]
Strapatsas, Judith; Barbulescu, Elena Calina; Lauseker, Michael; Kaivers, Jennifer; Hildebrandt, Barbara; Nachtkamp, Kathrin; Strupp, Corinna; Rudelius, Martina; Haas, Rainer und Germing, Ulrich
(2021):
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
In: Annals of Hematology, Bd. 100: S. 2575-2584
[PDF, 891kB]
Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin und Tonn, Joerg-Christian
(2021):
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.
In: Acta neuropathologica communications, Bd. 9, Nr. 1: S. 35
[PDF, 1MB]
Kaufmann, Elisabeth; Hordt, Mirjam; Lauseker, Michael; Palm, Ulrich und Noachtar, Soheyl
(2021):
Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsies.
In: Clinical Neurophysiology, Bd. 132, Nr. 7: S. 1444-1451
Rautenberg, Christina; Lauseker, Michael; Kaivers, Jennifer; Jäger, Paul; Fischermanns, Carolin; Pechtel, Sabrina; Haas, Rainer; Kobbe, Guido; Germing, Ulrich und Schroeder, Thomas
(2021):
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.
In: European Journal of Haematology
[PDF, 526kB]
Schüttler, Dominik; Hamm, Wolfgang; Krammer, Simone; Steffen, Julius; Deuster, Eileen; Lauseker, Michael; Egger, Florian; Meyer, Tim und Brunner, Stefan
(2021):
Staying on the ball during COVID-19 pandemic: impact on training modalities in football players.
In: The Journal of Sports Medicine and Physical Fitness 2021, Bd. 62, Nr. 5: S. 595-601
Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin und Tonn, Joerg-Christian
(2021):
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.
In: Acta Neuropathologica Communications, Bd. 9, Nr. 35
[PDF, 1MB]
Rautenberg, Christina; Germing, Ulrich; Stepanow, Stefanie; Lauseker, Michael; Köhrer, Paul S.; Geyh, Stefanie; Fan, Min; Haas, Rainer; Kobbe, Guido und Schroeder, Thomas
(2021):
Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.
In: American Journal of Hematology, Bd. 96, Nr. 1, E15-E17
[PDF, 1MB]
Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M. und Müller, Martin C.
(2021):
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.
In: Leukemia & Lymphoma: S. 1-8
Egeli, Damla Buket; Hanfstein, Benjamin; Lauseker, Michael; Pfirrmann, Markus; Saussele, Susanne; Baerlocher, Gabriela M. und Müller, Martin C.
(2021):
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.
In: Leukemia & Lymphoma, Bd. 63, Nr. 4: S. 955-962
Kaufmann, Elisabeth; Hordt, Mirjam; Lauseker, Michael; Palm, Ulrich und Noachtar, Soheyl
(2021):
Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsies.
In: Clinical Neurophysiology, Bd. 132, Nr. 7: S. 1444-1451
Rautenberg, Christina; Lauseker, Michael; Kaivers, Jennifer; Jäger, Paul; Fischermanns, Carolin; Pechtel, Sabrina; Haas, Rainer; Kobbe, Guido; Germing, Ulrich und Schroeder, Thomas
(2021):
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.
In: European Journal of Haematology, Bd. 107, Nr. 2: S. 283-292
Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Bd. 11, Nr. 10, 164
Siller, Sebastian; Lauseker, Michael; Karschnia, Philipp; Niyazi, Maximilian; Eigenbrod, Sabina; Giese, Armin und Tonn, Jörg-Christian
(2021):
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.
In: Acta Neuropathologica Communications, Bd. 9, Nr. 1, 35
Strapatsas, Judith; Barbulescu, Elena Calina; Lauseker, Michael; Kaivers, Jennifer; Hildebrandt, Barbara; Nachtkamp, Kathrin; Strupp, Corinna; Rudelius, Martina; Haas, Rainer und Germing, Ulrich
(2021):
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
In: Annals of Hematology, Bd. 100, Nr. 10: S. 2575-2584
Leuschner, Gabriela; Lauseker, Michael; Howanietz, Anne-Sophie; Milger, Katrin; Veit, Tobias; Munker, Dieter; Schneider, Christian; Weig, Thomas; Michel, Sebastian; Barton, Jürgen; Meiser, Bruno; Dinkel, Julien; Neurohr, Claus; Behr, Jürgen und Kneidinger, Nikolaus
(2020):
Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
In: Journal of heart and lung transplantation, Bd. 39, Nr. 11: S. 1270-1278
Klemme, M.; Staffler, A.; Maio, N. de; Lauseker, Michael; Schubert, S.; Innocenti, P.; Wurster, T. M.; Foerster, K.; Herber-Jonat, S.; Mittal, R.; Messner, H. und Flemmer, A. W.
(2020):
Use of impregnated catheters to decrease colonization rates in neonates - a randomized controlled pilot trial.
In: Journal of Neonatal-Perinatal Medicine, Bd. 13, Nr. 2: S. 231-37
Wolf, Sebastian; Lauseker, Michael; Schiergens, Tobias S.; Wirth, Ulrich; Drefs, Moritz; Renz, Bernhard; Ryll, Martin; Bucher, Julian; Werner, Jens; Guba, Markus und Andrassy, Joachim
(2020):
Infections after kidney transplantation: A comparison of mTOR-Is and CNIs as basic immunosuppressants. A systematic review and meta-analysis.
In: Transplant infectious disease: an official journal of the Transplantation Society, Bd. 22, Nr. 3, e13267
[PDF, 1MB]
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Hasford, Jörg und Kolb, Hans-Jochem
(2020):
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
In: Leukemia, Bd. 34: S. 2074-2086
[PDF, 1MB]
Wolf, Sebastian; Lauseker, Michael; Schiergens, Tobias S.; Wirth, Ulrich; Drefs, Moritz; Renz, Bernhard; Ryll, Martin; Bucher, Julian; Werner, Jens; Guba, Markus und Andrassy, Joachim
(2020):
Infections after kidney transplantation: A comparison of mTOR‐Is and CNIs as basic immunosuppressants. A systematic review and meta‐analysis.
In: Transplant Infectious Disease, Bd. 22, Nr. 3, e13267
[PDF, 1MB]
Laubender, Ruediger P.; Mansmann, Ulrich und Lauseker, Michael
(2020):
Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel‐group RCT: A structural model approach.
In: Biometrical Journal, Bd. 62, Nr. 3: S. 697-711
[PDF, 1MB]
Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, François; Hasford, Joerg; Hochhaus, Andreas und Hoffmann, Verena S.
(2020):
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
In: Leukemia, Bd. 34, Nr. 8: S. 2138-2149
[PDF, 969kB]
Kaufmann, Elisabeth; Seethaler, Magdalena; Lauseker, Michael; Fan, Min; Vollmar, Christian; Noachtar, Soheyl und Rémi, Jan
(2020):
Who seizes longest? Impact of clinical and demographic factors.
In: Epilepsia, Bd. 61, Nr. 7: S. 1376-1385
[PDF, 1MB]
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael und Pfirrmann, Markus
(2020):
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
In: Leukemia, Bd. 34, Nr. 10, 2823
Seethaler, Magdalena; Lauseker, Michael; Ernst, Katharina; Rémi, Jan; Vollmar, Christian; Noachtar, Soheyl und Kaufmann, Elisabeth
(2020):
Hemispheric differences in the duration of focal onset seizures.
In: Acta neurologica Scandinavica, Bd. 143, Nr. 3: S. 248-255
[PDF, 514kB]
Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Strömberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas und Pfirrmann, Markus
(November 2019):
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
In: American Journal of Hematology, Bd. 94, Nr. 11: S. 1236-1243
[PDF, 1MB]
Lauseker, Michael; Gerlach, Roman; Worseg, Wenke; Haferlach, Torsten; Tauscher, Martin; Hasford, Joerg und Hoffmann, Verena S.
(Oktober 2019):
Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study.
In: European Journal of Haematology, Bd. 103, Nr. 4: S. 362-369
[PDF, 543kB]
Schroeder, Thomas; Wegener, Nadija; Lauseker, Michael; Rautenberg, Christina; Nachtkamp, Kathrin; Schuler, Esther; Kondakci, Mustafa; Haas, Rainer; Germing, Ulrich und Kobbe, Guido
(2019):
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.
In: Biology of Blood and Marrow Transplantation, Bd. 25, Nr. 8: S. 1550-1559
Hartl, E.; Seethaler, M.; Lauseker, Michael; Rémi, J.; Vollmar, C. und Noachtar, S.
(2019):
Impact of withdrawal of antiepileptic medication on the duration of focal onset seizures.
In: Seizure-European Journal of Epilepsy, Bd. 67: S. 40-44
Fankhauser, Maria; Bechmann, Nicole; Lauseker, Michael; Goncalves, Judith; Favier, Judith; Klink, Barbara; William, Doreen; Gieldon, Laura; Maurer, Julian; Spöttl, Gerald; Rank, Petra; Knösel, Thomas; Orth, Michael; Ziegler, Christian G.; Aristizabal Prada, Elke Tatjana; Rubinstein, German; Fassnacht, Martin; Spitzweg, Christine; Grossman, Ashley B.; Pacak, Karel; Beuschlein, Felix; Bornstein, Stefan R.; Eisenhofer, Graeme; Auernhammer, Christoph J.; Reincke, Martin und Nölting, Svenja
(2019):
Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.
In: Endocrinology, Bd. 160, Nr. 11: S. 2600-2617
Lauseker, Michael und Eulenburg, Christine zu
(2019):
Analysis of cause of death: Competing risks or progressive illness-death model?
In: Biometrical Journal, Bd. 61, Nr. 2: S. 264-274
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus
(2019):
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
In: Haematologica, Bd. 104, Nr. 5: S. 955-962
Aristizabal Prada, Elke Tatjana; Weis, Carla; Orth, Michael; Lauseker, Michael; Spöttl, Gerald; Maurer, Julian; Grabowski, Patricia; Grossman, Ashley; Auernhammer, Christoph Josef und Nölting, Svenja
(2. Oktober 2018):
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors?
In: Neuroendocrinology, Bd. 106, Nr. 4: S. 335-351
Andrassy, Joachim; Wolf, S.; Lauseker, Michael; Angele, Martin K.; van Rosmalen, M. D.; Samuel, U.; Rogiers, X.; Werner, J. und Guba, Markus
(Januar 2018):
Higher Retransplantation rate following Extended Right Split-Liver Transplantation - an analysis from the Eurotransplant Liver follow-up Registry.
In: Liver Transplantation, Bd. 24, Nr. 1: S. 26-34
Kühnemuth, Benjamin; Piseddu, Ignazio; Wiedemann, Gabriela M.; Lauseker, Michael; Kuhn, Christina; Hofmann, Simone; Schmoeckel, Elisa; Endres, Stefan; Mayr, Doris; Jeschke, Udo und Anz, David
(2018):
CCL1 is a major regulatory T cell attracting factor in human breast cancer.
In: BMC Cancer
:18:1278
[PDF, 914kB]
Schönberg, Markus Bo; Anger, Hubertus Johann Wolfgang; Hao, Jingcheng; Vater, Adrian; Bucher, Julian Nikolaus; Thomas, Michael Nikolaus; Lauseker, Michael; Rentsch, Markus; Schiergens, Tobias S.; Angele, Martin Kurt; Bazhin, Alexandr V.; Werner, Jens und Guba, Markus Otto
(2018):
Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.
In: Surgical Oncology, Bd. 27, Nr. 4: S. 663-673
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas und Lauseker, Michael
(2018):
Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV.
In: Leukemia, Bd. 32, Nr. 5: S. 1222-1228
[PDF, 599kB]
Kuendgen, Andrea; Müller-Thomas, Catharina; Lauseker, Michael; Haferlach, Torsten; Urbaniak, Petra; Schroeder, Thomas; Brings, Carolin; Wulfert, Michael; Meggendorfer, Manja; Hildebrandt, Barbara; Betz, Beate; Royer-Pokora, Brigitte; Gattermann, Norbert; Haas, Rainer; Germing, Ulrich und Götze, Katharina S.
(2018):
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.
In: Oncotarget, Bd. 9, Nr. 45: S. 27882-27894
Kaivers, J.; Lauseker, Michael; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Latagliata, R.; Oliva, E. N.; Xicoy, B.; Götze, K.; Ganster, C.; Haase, D.; Bug, G.; Kündgen, A.; Gattermann, N.; Haas, R. und Germing, U.
(2018):
The IPSS-R has prognostic impact in untreated patients with MDS del(5q).
In: Leukemia Research, Bd. 72: S. 27-33
Aristizabal Prada, Elke Tatjana; Spöttl, Gerald; Maurer, Julian; Lauseker, Michael; Koziolek, Eva Jolanthe; Schrader, Jörg; Grossman, Ashley; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph Joseph und Nölting, Svenja
(2018):
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.
In: Endocrine-Related Cancer, Bd. 25, Nr. 10: S. 893-908
Lauseker, Michael; Hasford, Joerg; Saussele, Susanne; Kremers, Stephan; Kraemer, Doris; Lindemann, Walter; Hehlmann, Rüdiger und Pfirrmann, Markus
(2017):
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
In: Cancer, Bd. 123, Nr. 13: S. 2467-2471
Nölting, Svenja; Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Möbs, Markus; Weissmann, Victoria; Siegmund, Britta; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal; Lauseker, Michael; Grossman, Ashley; Exner, Samantha; Fischer, Christian; Schrader, Jörg und Grabowski, Patricia
(2017):
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
Neukirchen, Judith; Lauseker, Michael; Hildebrandt, Barbara; Nolting, Ann-Christin; Kaivers, Jennifer; Kobbe, Guido; Gattermann, Norbert; Haas, Rainer und Germing, Ulrich
(2017):
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
In: Cancer
Andrassy, Joachim; Wolf, Sebastian; Lauseker, Michael; Angele, Martin; Samuel, Undine; Rogiers, Xavier; Werner, Jens und Guba, Markus
(2017):
Shipping Of Split-Livers Results in A Higher Retransplantation Rate But Does Not Affect Overall Patient's Survival: An Analysis from the Eurotransplant Liver Follow-Up Registry.
In: Transplant international, Bd. 30: S. 105
Hehlmann, Rüdiger; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas; Hasford, Joerg; Pfirrmann, Markus; Kolb, Hans-Jochem; Spiekermann, Karsten; Fabarius, Alice; Müller, M. C.; Proetel, Ulrike; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spieß, B.; Krause, S. W.; Neubauer, A.; Burchert, A.; Hossfeld, Dieter K.; Schafhausen, P.; Nerl, C.; Gratwohl, A.; Heim, D.; Baerlocher, Gabriela M.; Brümmendorf, Tim H.; Fuchs, R.; Haferlach, C.; Jeromin, S.; Schlegelberger, Brigitte; Balleisen, L.; Goebeler, M. C.; Hänel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Kneba, M.; Stegelmann, F.; Köhne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, Michael; Berdel, Wolfgang E.; Müller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, Bernd; Wernli, Martin; Schlegel, F.; Schlag, R.; Wit, M. de; Trumper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S. und Schäfer, E.
(2017):
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
In: Leukemia, Bd. 31, Nr. 11: S. 2398-2406
Miranda, M. B.; Lauseker, Michael; Kraus, M. P.; Proetel, U.; Hanfstein, B.; Fabarius, A.; Baerlocher, Gabriela M.; Heim, D.; Hossfeld, D. K.; Kolb, H. J.; Krause, S. W.; Nerl, C.; Brümmendorf, Tim H.; Verbeek, W.; Fauser, A. A.; Prummer, O.; Neben, K.; Hess, U.; Mahlberg, R.; Ploger, C.; Flasshove, M.; Rendenbach, B.; Hofmann, W. K.; Muller, M. C.; Pfirrmann, Markus; Hochhaus, A.; Hasford, Joerg; Hehlmann, R. und Saußele, Susanne
(2016):
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
In: Leukemia, Bd. 30, Nr. 6: S. 1255-1262
Lauseker, Michael; Gerlach, R.; Tauscher, M. und Hasford, Joerg
(2016):
Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 7: S. 1441-1447
Fabarius, A.; Kalmanti, L.; Dietz, C. T.; Lauseker, Michael; Rinaldetti, S.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Jotterand, M.; Hanfstein, B.; Seifarth, W.; Hänel, M.; Köhne, C. H.; Lindemann, H. W.; Berdel, W. E.; Staib, P.; Müller, M. C.; Proetel, U.; Balleisen, L.; Goebeler, M. E.; Dengler, J.; Falge, C.; Kanz, L.; Burchert, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Brümmendorf, Tim H.; Edinger, M.; Hofmann, W. K.; Pfirrmann, Markus; Hasford, Joerg; Krause, S.; Hochhaus, A.; Saußele, Susanne und Hehlmann, R.
(2015):
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
In: Annals of Hematology, Bd. 94, Nr. 12: S. 2015-2024
Kalmanti, L.; Saußele, Susanne; Lauseker, Michael; Muller, M. C.; Dietz, C. T.; Heinrich, L.; Hanfstein, B.; Proetel, U.; Fabarius, A.; Krause, S. W.; Rinaldetti, S.; Dengler, J.; Falge, C.; Oppliger-Leibundgut, E.; Burchert, A.; Neubauer, A.; Kanz, L.; Stegelmann, F.; Pfreundschuh, M.; Spiekermann, Karsten; Scheid, C.; Pfirrmann, Markus; Hochhaus, A.; Hasford, Joerg und Hehlmann, R.
(2015):
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.
In: Leukemia, Bd. 29, Nr. 5: S. 1123-1132
Saußele, Susanne; Krauß, M. P.; Hehlmann, R.; Lauseker, Michael; Proetel, U.; Kalmanti, L.; Hanfstein, B.; Fabarius, A.; Kraemer, D.; Berdel, W. E.; Bentz, M.; Staib, P.; de Wit, M.; Wernli, M.; Zettl, F.; Hebart, H. F.; Hahn, M.; Heymanns, J.; Schmidt-Wolf, I.; Schmitz, N.; Eckart, M. J.; Gassmann, W.; Bartholomäus, A.; Pezzutto, A.; Oppliger Leibundgut, E.; Heim, D.; Krause, S. W.; Burchert, A.; Hofmann, W. K.; Hasford, Joerg; Hochhaus, A.; Pfirrmann, Markus und Müller, M. C.
(2015):
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
In: Blood, Bd. 126, Nr. 1: S. 42-49
Lauseker, Michael; Schemenau, J.; Strupp, C.; Kundgen, A.; Gattermann, N.; Hasford, Joerg und Germing, U.
(2015):
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.
In: British Journal of Haematology, Bd. 170, Nr. 5: S. 687-693
Lauseker, Michael; Hasford, Joerg; Hoffmann, V. S.; Mueller, M. C.; Hehlmann, R. und Pfirrmann, Markus
(2015):
A multi-state model approach for prediction in chronic myeloid leukaemia.
In: Annals of Hematology, Bd. 94, Nr. 6: S. 919-927
Lauseker, Michael
(2015):
Reflections on the true nature of spatial clusters in myelodysplastic syndromes.
In: Leukemia & Lymphoma: S. 1-2
Oliva, Esther N.; Lauseker, Michael; Spiriti, Maria Antonietta Aloe; Poloni, Antonella; Cortelezzi, Agostino; Palumbo, Giuseppe A.; Balleari, Enrico; Sanpaolo, Grazia; Volpe, Antonio; Ricco, Alessandra; Ronco, Francesca; Alati, Caterina; D'Errigo, Maria Grazia; Santacaterina, Irene; Kuendgen, Andrea; Germing, Ulrich und Latagliata, Roberto
(2015):
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
In: Cancer Medicine, Bd. 4, Nr. 12: S. 1789-1797
[PDF, 257kB]
Pfirrmann, Markus; Lauseker, Michael; Hoffmann, V. S. und Hasford, Joerg
(2015):
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.
In: Annals of Hematology / Supplements, Bd. 94, Nr. 2:
S209-18
Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T.; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas und Müller, Martin C.
(November 2014):
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
In: Journal of cancer research and clinical oncology, Bd. 140, Nr. 11: S. 1965-1969
Hanfstein, B.; Shlyakhto, V.; Lauseker, Michael; Hehlmann, R.; Saussele, S.; Dietz, C. T.; Erben, P.; Fabarius, A.; Proetel, U.; Schnittger, S.; Krause, S. W.; Schubert, J.; Einsele, H.; Hänel, M.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, K.; Baerlocher, G. M.; Pfirrmann, Markus; Hasford, Joerg; Hofmann, W. K.; Hochhaus, A. und Muller, M. C.
(Oktober 2014):
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib.
In: Leukemia, Bd. 28, Nr. 10: S. 1988-1992
Hehlmann, Rüdiger; Hasford, Joerg; Pfirrmann, Markus; Lauseker, Michael; Saußele, Susanne und Hochhaus, Andreas
(September 2014):
Reply to H. Kantarjian et al.
In: Journal of Clinical Oncology, Bd. 32, Nr. 27, 3078-3078
Nölting, Svenja; Giubellino, Alessio; Tayem, Yasin; Young, Karen; Lauseker, Michael; Bullova, Petra; Schovanek, Jan; Anver, Miriam; Fliedner, Stephanie; Korbonits, Marta; Göke, Burkhard; Vlotides, George; Grossman, Ashley und Pacak, Karel
(Juli 2014):
Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice.
In: Endocrinology, Bd. 155, Nr. 7: S. 2377-2390
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger und Saußele, Susanne
(Juli 2014):
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
In: Annals of Hematology, Bd. 93, Nr. 7: S. 1167-1176
[PDF, 985kB]
Lauseker, Michael; Hasford, Joerg; Pfirrmann, Markus und Hehlmann, Rüdiger
(April 2014):
The impact of health care settings on survival time of patients with chronic myeloid leukemia.
In: Blood, Bd. 123, Nr. 16: S. 2494-2496
Strobel, H.; Lauseker, Michael und Forbes, A. B.
(Januar 2014):
Targeted antibiotic treatment of lame sheep with footrot using either oxytetracycline or gamithromycin.
In: Veterinary Record, Bd. 147, Nr. 2: S. 46
Neukirchen, J.; Lauseker, Michael; Blum, S.; Giagounidis, A.; Lubbert, M.; Martino, S.; Siragusa, S.; Schlenk, R. F.; Platzbecker, U.; Hofmann, W. K.; Gotze, K.; Palumbo, G. A.; Magrin, S.; Kundgen, A.; Aul, C.; Hildebrandt, B.; Hasford, Joerg; Kobbe, G.; Haas, R. und Germing, U.
(2014):
Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study.
In: Leukemia Research, Bd. 38, Nr. 1: S. 57-64
Kalmanti, L.; Saußele, Susanne; Lauseker, Michael; Proetel, U.; Muller, M. C.; Hanfstein, B.; Schreiber, A.; Fabarius, A.; Pfirrmann, Markus; Schnittger, S.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Krause, S. W.; Heim, D.; Nerl, C.; Hossfeld, D. K.; Kolb, H. J.; Hochhaus, A.; Hasford, Joerg und Hehlmann, R.
(2014):
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
In: Annals of Hematology, Bd. 93, Nr. 1: S. 71-80
Hehlmann, R.; Müller, M. C.; Lauseker, Michael; Hanfstein, B.; Fabarius, A.; Schreiber, A.; Proetel, U.; Pletsch, N.; Pfirrmann, Markus; Haferlach, C.; Schnittger, S.; Einsele, H.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Ehninger, G.; Heim, D.; Heimpel, H.; Nerl, C.; Krause, S. W.; Hossfeld, D. K.; Kolb, H. J.; Hasford, Joerg; Saußele, Susanne und Hochhaus, A.
(2014):
Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV.
In: Journal of Clinical Oncology, Bd. 32, Nr. 5: S. 415-423
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Bd. 99, Nr. 9: S. 1441-1447
[PDF, 784kB]
Lauseker, Michael und Hasford, Joerg
(2014):
Remission status should not be treated as a base-line covariate – Reply to Etienne et al.
In: Haematologica, Bd. 99, Nr. 9, e174-e175
Kuendgen, A.; Lauseker, Michael; List, A. F.; Fenaux, P.; Giagounidis, A. A.; Brandenburg, N. A.; Backstrom, J.; Glasmacher, A.; Hasford, Joerg und Germing, U.
(2013):
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis.
In: Leukemia, Bd. 27, Nr. 5: S. 1072-1079
Lauseker, Michael; Pfirrmann, Markus; Hoffmann, V. S. und Hasford, Joerg
(Mai 2012):
Comment On “Second-Generation Tyrosine Kinase Inhibitors Improve The Survival Of Patients With Chronic Myeloid Leukemia In Whom Imatinib Therapy Has Failed” Haematologica 2011;96(12):1779–82.
In: Haematologica, Bd. 97, Nr. 5, e14-e15
Germing, U.; Lauseker, Michael; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Fenaux, P.; Kelaidi, C.; Pfeilstöcker, M.; Nösslinger, T.; Sekeres, M.; Maciejewski, J.; Haase, D.; Schanz, J.; Seymour, J.; Kenealy, M.; Weide, R.; Lübbert, M.; Platzbecker, U.; Valent, P.; Götze, K.; Stauder, R.; Blum, S.; Kreuzer, K. A.; Schlenk, R.; Ganser, A.; Hofmann, W. K.; Aul, C.; Krieger, O.; Kundgen, A.; Haas, R.; Hasford, Joerg und Giagounidis, A.
(2012):
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study.
In: Leukemia, Bd. 26, Nr. 6: S. 1286-1292
Hanfstein, B.; Müller, M. C.; Hehlmann, R.; Erben, P.; Lauseker, Michael; Fabarius, A.; Schnittger, S.; Haferlach, C.; Göhring, G.; Proetel, U.; Kolb, H. J.; Krause, S. W.; Hofmann, W. K.; Schubert, J.; Einsele, H.; Dengler, J.; Hänel, M.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Branford, S.; Hughes, T. P.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Joerg; Saußele, Susanne und Hochhaus, A.
(2012):
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 26, Nr. 9: S. 2096-2102
Nölting, Svenja; Kuttner, Axel; Lauseker, Michael; Vogeser, Michael; Haug, Alexander; Herrmann, Karin A.; Hoffmann, Johannes N.; Spitzweg, Christine; Göke, Burkhard und Auernhammer, Christoph J.
(2012):
Chromogranin A as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
In: Cancers, Bd. 4, Nr. 1: S. 141-155
[PDF, 158kB]
Fabarius, A.; Leitner, A.; Hochhaus, A.; Müller, M. C.; Hanfstein, B.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Jotterand, M.; Reiter, A.; Jung-Munkwitz, S.; Proetel, U.; Schwaab, J.; Hofmann, W. K.; Schubert, J.; Einsele, H.; Ho, A. D.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Lauseker, Michael; Pfirrmann, Markus; Hasford, Joerg; Saußele, Susanne und Hehlmann, R.
(2011):
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: Long-term observation of 1151 patients from the randomized CML Study IV.
In: Blood, Bd. 118, Nr. 26: S. 6760-6768
Hehlmann, R.; Lauseker, Michael; Jung-Munkwitz, S.; Leitner, A.; Müller, M. C.; Pletsch, N.; Proetel, U.; Haferlach, C.; Schlegelberger, B.; Balleisen, L.; Hänel, M.; Pfirrmann, Markus; Krause, S. W.; Nerl, C.; Pralle, H.; Gratwohl, A.; Hossfeld, D. K.; Hasford, Joerg; Hochhaus, A. und Saußele, Susanne
(2011):
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-alpha in newly diagnosed chronic myeloid leukemia.
In: Journal of Clinical Oncology, Bd. 29, Nr. 12: S. 1634-1642
Pfirrmann, Markus; Hochhaus, A.; Lauseker, Michael; Saußele, Susanne; Hehlmann, R. und Hasford, Joerg
(2011):
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia.
In: Leukemia, Bd. 25, Nr. 9: S. 1433-1438
Saußele, Susanne; Lauseker, Michael; Gratwohl, A.; Beelen, D. W.; Bunjes, D.; Schwerdtfeger, R.; Kolb, H. J.; Ho, A. D.; Falge, C.; Holler, E.; Schlimok, G.; Zander, A. R.; Arnold, R.; Kanz, L.; Dengler, R.; Haferlach, C.; Schlegelberger, B.; Pfirrmann, Markus; Müller, M. C.; Schnittger, S.; Leitner, A.; Pletsch, N.; Hochhaus, A.; Hasford, Joerg und Hehlmann, R.
(2010):
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
In: Blood, Bd. 115, Nr. 10: S. 1880-1885